Value of promoter methylation of RASSFlA, p 16, and DAPK genes in induced sputum in diagnosing lung cancers

Journal of Central South University (Medical Sciences)

Volumn 35, Issue 3, 2010, Pages 247-253

  Peng, Zaimei ^a   Shan, Changting ^b   Wang, Huifang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b JINING MEDICAL UNIVERSITY   (China)

Author keywords

Diagnosis; DNA methylation; Methylation specific PCR; P16 Death associated protein kinase gene; Pulmonary neoplasm; Ras association domain family 1A gene

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DEATH ASSOCIATED PROTEIN KINASE; DEATH-ASSOCIATED PROTEIN KINASE; RASSF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADENOCARCINOMA; AGED; ARTICLE; DNA METHYLATION; FEMALE; GENETICS; HUMAN; LUNG TUMOR; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROMOTER REGION; SPUTUM; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; SPUTUM; TUMOR SUPPRESSOR PROTEINS;

EID: 77951489418     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2010.03.010     Document Type: Article

References (17)

1. Jones P A , Baylin S B. The fundamental role of epigenetic events in cancer [J]. Nat Rav Genet ,2002, 3(6) : 415 -428.
2. Yanagawa N , Tamura G , Oizumi H , et al. Promoter hypermethylation of RASSFlA and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers [J]. Lung Cancer, 2007 ,58 (1) : 13 1 138.
3. Belinsky S A , Palmisano W A , Gilliland F D , et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers [J]. Cancer Res , 2002 , 62 (8) :2370-2377.
4. Pulling L C , Divine K K , Klinge D M , et al. Promoter hypermethylation of the 06-methyluanine-DNA methyltransferase gene ; more common in lung adenocarcinomas from neversmokers than smokers and associated with tumor progression [J]. Cancer Res ,2003 ,63 ( 16 ) :4842-4848.
5. Russo A L , Thiagalingam A , Pan H , et al. Differential DNA hypermethylation of critical genes mediates the stage - specific tobacco smoker - induced neoplastic progression of lung cancer [J]. Clin Cancer Res, 2005, 11 (7) :2466-2470.
6. Burbee D G , Forgacs E , Zochbauer-Müller S , et al. Epigenetic inactivation of RASSFlA in lung and breast cancers and malignant phenotype suppression [J]-J Natl Cancer Inst, 2001, 93 (9) : 691-699.
7. Dammann R , Schagdarsurengin U , Seidel C , et al. The tumor suppressor RASSFl A in human carcinogenesis : an update [J]. Histopathology , 2005, 20(2) : 645-663.
8. Liu Y , Lan Q , Siegfried J M , et al. Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients [J]. Neoplasia, 2006,8 (1) :46-51.
9. Liu Y , Gao W , Siegfried J M , et al. Promoter methylation of RASSFlA and DAPK and mutations of K-ras, p 53, and EGFR in lung tumors from smokers and never-smokers [J]. BMC Cancer, 2007, 7 :74.
10. Hemann J G , Graff J R , Myohanen S , et al. Methyladon specific PCR : a novel PCR assay for methylation status of CpG islands [J]. Proc Antl Acad Sei USA, 1996, 93 (18) : 9821-9826. (Pubitemid 26296693)
11. PENG Hong, CHEN Ping. The change of concentration of endothelin derived from alveolar macrophages and in induced sputum in patients with chronic bronchitis [J]. Chinese Journal of Tuberculosis and Resporatory Diseases, 2001 , 24 (6)-351-354.
12. Waki T , Tamura G , Sato M , et al. Age - related methylation of tumor suppresson and tumor-related genes an analysis of autopsysamples [J]. Oncogene, 2003 ,22 ( 26 ) ; 4128-4133.
13. Wang J. Lee J J , Wang L, et al. Value of p 16 INK4 a and RASSFlA promoter hypermethylation in prognosis of patients with respectable non - small cell lung cancer [J]. Clin Cancer Res.2004,10(18) : 6119-6125.
14. Tomizawa Y , Kohno T, Kondo H , et al. Clinicopathological significance of epigenetic inactivation of RASSFl A at 3p21.3 in stage I lungadenocarcinoma [J]. Clin Cancer Res ,2002 , 8(7) ;2362-2368.
15. YANG Zhenhua , CAI Yingyun , SUN Lihua et al. The change ofp/6INK4a and RASSFIA promoter methylation in nonsmall cell lung cancer [J]. Journal of Practical Oncology , 2007, 22(2) : 53-156.
16. Liu Y , An Q , Li L, et al. Hypermethylation of p 16 1 NK4 a in Chinese lung cancer patients : biological and clinical implications [J]. Carcinogenesis, 2003 ,24 ( 12 ) 1897-1901.
17. Fujiwara K , Fujimoto N , Tabata M , et al. Identification of episenetic aberrant promoter methylation in serum DNA : Is useful for early detection of lung cancer [J]. Clin Cancer Res, 2005,11 (3) 1219-1225. (Pubitemid 40175774)